The role of virgin olive oil components in the modulation of endothelial function

被引:194
作者
Perona, Javier S. [1 ]
Cabello-Moruno, Rosana [1 ]
Ruiz-Gutierrez, Valentina [1 ]
机构
[1] CSIC, Inst Grasa, Nutr & Lipid Metab Grp, E-41012 Seville, Spain
关键词
adhesion molecules; endothelium; nitric oxide; reactive oxygen species; virgin olive oil;
D O I
10.1016/j.jnutbio.2005.11.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The endothelium is involved in many of the processes related to the development of atherosclerosis, which is considered an inflammatory disease. Actually, traditional risk factors for atherosclerosis predispose to endothelial dysfunction, which is manifested as an increase in the expression of specific cytokines and adhesion molecules. There are firm evidence supporting the beneficial effects of olive oil, the most genuine component of the Mediterranean diet. Although the effects of olive oil and other oleie acid-rich dietary oils on atherosclerosis and plasma lipids are well known, the roles of minor components have been less investigated. Minor components constitute only 1-2% of virgin olive oil (VOO) and are composed of hydrocarbons, polyphenols, tocopherols, sterols, triterpenoids and other components usually found in traces. Despite their low concentration, non-fatty acid constituents may be of importance because studies comparing monounsaturated dietary oils have reported different effects on cardiovascular disease. Most of these compounds have demonstrated antioxidant, anti-inflammatory and hypolipidemic properties. In this review, we summarize current knowledge on the effects of these compounds contained in VOO on vascular dysfunction and the mechanisms by which they modulate endothelial activity. Such mechanisms involve the release of nitric oxide, eicosanoids (prostaglandins and leukotrienes) and adhesion molecules, in most cases by activation of nuclear factor kappa B by reactive oxygen species. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:429 / 445
页数:17
相关论文
共 238 条
[81]   The effect of α-tocopherol on monocyte proatherogenic activity [J].
Jialal, I ;
Devaraj, S ;
Kaul, N .
JOURNAL OF NUTRITION, 2001, 131 (02) :389S-394S
[82]   THE EFFECT OF ALPHA-TOCOPHEROL SUPPLEMENTATION ON LDL OXIDATION - A DOSE-RESPONSE STUDY [J].
JIALAL, I ;
FULLER, CJ ;
HUET, BA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (02) :190-198
[83]   Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase [J].
Jin, WJ ;
Sun, GS ;
Marchadier, D ;
Octtaviani, E ;
Glick, JM ;
Rader, DJ .
CIRCULATION RESEARCH, 2003, 92 (06) :644-650
[84]   The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease [J].
Johansen, O ;
Seljeflot, I ;
Hostmark, AT ;
Arensen, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (07) :1681-1686
[85]   Dietary phytosterols as cholesterol-lowering agents in humans [J].
Jones, PJH ;
MacDougall, DE ;
Ntanios, F ;
Vanstone, CA .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (03) :217-227
[86]   Nitric oxide and renal autoregulation [J].
Just, A .
KIDNEY & BLOOD PRESSURE RESEARCH, 1997, 20 (03) :201-204
[87]   Endothelial cell monolayer dysfunction caused by oxidized low density lipoprotein: Attenuation by oleic acid [J].
Karman, RJ ;
Garcia, JGN ;
Hart, CM .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1997, 56 (05) :345-353
[88]   ATHEROSCLEROSIS, OXIDATIVE STRESS, AND ANTIOXIDANT PROTECTION IN ENDOTHELIUM-DERIVED RELAXING FACTOR ACTION [J].
KEANEY, JF ;
VITA, JA .
PROGRESS IN CARDIOVASCULAR DISEASES, 1995, 38 (02) :129-154
[89]   Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects [J].
Kelm, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (01) :H1-H5
[90]   Superoxide anion production is increased in a model of genetic hypertension - Role of the endothelium [J].
Kerr, S ;
Brosnan, MJ ;
McIntyre, M ;
Reid, JL ;
Dominiczak, AF ;
Hamilton, CA .
HYPERTENSION, 1999, 33 (06) :1353-1358